Why We Make War on Some Drugs but Not on Others A Short History of - PowerPoint PPT Presentation

Feb 25, 2024 •245 likes •628 views

Why We Make War on Some Drugs but Not on Others A Short History of Drug Use and Drug Policy David T. Courtwright dcourtwr@unf.edu LSE October 23, 2012 I have seen with my own eyes the terrible scourge drink can be. It has ruined people

Why We Make War on Some Drugs but Not on Others A Short History of Drug Use and Drug Policy David T. Courtwright dcourtwr@unf.edu LSE October 23, 2012
I have seen with my own eyes the terrible scourge drink can be. It has ruined people morally, physically, economically, and it has destroyed the sanctity of the home. . . .Large numbers of Negro labourers are seen to waste all their earnings in drinking so that their lives become devoid of any grace. --Mohandas Gandhi
The double- double standard has become the single-double standard.
Why We Make War on Some Drugs but Not on Others A Short History of Drug Use and Drug Policy David T. Courtwright dcourtwr@unf.edu LSE October 23, 2012
Past MJ use among persons aged 18-25, U.S.

Recommend

F They tried to make me go to rehab . Drugs, young people and the law Jane Sanders,

F They tried to make me go to rehab . Drugs, young people and the law Jane Sanders, Principal Solicitor The Shopfront Youth Legal Centre Summary offences possession self-administration possession of equipment Options

451 views • 14 slides

DRUG FREE COMMITTEE Improving our Community through being Proactive Why? WHY NOT? Drugs are

DRUG FREE COMMITTEE Improving our Community through being Proactive Why? WHY NOT? Drugs are in our community and we believe that together, we can start to make a positive impact and help our citizens make educated choices. We are tired

375 views • 11 slides

Prescribing Drugs to Make Criminals Eligible for Punishment: A Violation of Medical Ethics?

Prescribing Drugs to Make Criminals Eligible for Punishment: A Violation of Medical Ethics? Douglas Mossman, M.D. Department of Psychiatry & Clinical Neuroscience University of Cincinnati College of Medicine Dr. Mossman has no financial

644 views • 48 slides

OUR AIMS To help those who are addicted to benzodiazepines and Z drugs and who wish to

OUR AIMS To help those who are addicted to benzodiazepines and Z drugs and who wish to withdraw from them to do so as comfortably as possible and to help them to make the changes necessary in life after withdrawal. To educate and inform

318 views • 11 slides

Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies

Just Say No! to Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies healthy? Getting exercise Eating lots of fruits and veggies Sleeping enough Saying no to drugs and alcohol What do

561 views • 18 slides

Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies

612 views • 14 slides

Lets Talk about Drugs Questions we hear from parents * What kind of drug experiences might

Lets Talk about Drugs Questions we hear from parents * What kind of drug experiences might my child face? * Whats the best way to talk to my child about drugs? * What can I do to make my child less vulnerable to developing problems

440 views • 27 slides

Bridging Molecular Timescales with MELD and Blue Waters Alberto Perez We need to know protein

Bridging Molecular Timescales with MELD and Blue Waters Alberto Perez We need to know protein structures to make new drugs DNA Protein sequence Protein structure Rational Drug Design We need to know protein structures to make new drugs

533 views • 18 slides

The Nervous System and Drugs How drugs affect the nervous system Adapted from Sylvia Maders in

The Nervous System and Drugs How drugs affect the nervous system Adapted from Sylvia Maders in class activities (McGrawHill) Objectives During this activity the students will: Explain the basic modes of action of several drugs and

326 views • 7 slides

New Drugs in AML New version of old drugs Inhibitors of signaling pathways CPX-351

New Drugs in AML New version of old drugs Inhibitors of signaling pathways CPX-351 FLT3 inhibitors Topo II inhibitors (Vosaroxin) PLK1 inhibitors (VolaserHb) Epigenetic modifiers Apoptosis inducers HMA

722 views • 35 slides

WILTSHIRE Drugs and Alcohol Strategy 2019-2022 Reducing harm caused by drugs and alcohol, to

WILTSHIRE Drugs and Alcohol Strategy 2019-2022 Reducing harm caused by drugs and alcohol, to improve healthier outcomes for Wiltshires communities The relationship with drugs and alcohol remains complex, and the challenges posed cannot be

403 views • 6 slides

The Drugs Dont Work Federica Dal Bello In the last decades the abuse of drugs raised the

The Drugs Dont Work Federica Dal Bello In the last decades the abuse of drugs raised the community attention because of the public health and the continuous growth of their use . Recently some scientific studies highlighted the consumption of

57 views • 4 slides

Drugs in Workplace Problem? 70% of estimated users of illegal drugs are employed Marijuana,

Drugs in Workplace Problem? 70% of estimated users of illegal drugs are employed Marijuana, cocaine, prescription drug 24% of workers report drinking at least once during work day in past year Cause 35% of injuries 38% to 50% of

388 views • 34 slides

PROTEIN DRUGS PEPTIDE AND PROTEIN DRUGS In this lecture, the general differences in the kinetic

Pharmacokinetics of PROTEIN DRUGS PEPTIDE AND PROTEIN DRUGS In this lecture, the general differences in the kinetic behavior of protein drugs relative to that observed with small molecules is emphasized. The kinetic behavior of antibody

720 views • 61 slides

Detection and Identification of Illicit Drugs and Cutting Agents in Seized Street Drugs: Benchtop

Detection and Identification of Illicit Drugs and Cutting Agents in Seized Street Drugs: Benchtop NMR Spectrometer & Databasing Software ACD/Labs User Meeting Susanne D. Riegel, Alexander F. G. Maier, Dimitris Argyropoulos, Marie Lange,

539 views • 50 slides

Newer Drugs for Myelofibrosis Giovanni Barosi Center for the Study of Myelofibrosis Fondazione

Newer Drugs for Myelofibrosis Giovanni Barosi Center for the Study of Myelofibrosis Fondazione IRCCS Policlinico S. Matteo Pavia, Italy New Drugs in Hematology Bologna, 9-11 May 2016 Specific targeted therapies for MF Category Drugs

290 views • 24 slides

? Part 1/3 Neurotransmitters How to alter neural activity Make more neurotransmitters

Drugs, Performance, Enhancement ? Part 1/3 Neurotransmitters How to alter neural activity Make more neurotransmitters Parkinsons Disease Give the brain the dopamine precursor (L-DOPA; levodopa) Slow down reuptake Depression

499 views • 34 slides

Surveillance Processes of Generic Drugs James Osterhout, PhD FDA Office of Generic Drugs

Surveillance Processes of Generic Drugs James Osterhout, PhD FDA Office of Generic Drugs Clinical Safety & Surveillance Staff 1 Potential Safety Signal Contacts from the public directly to FDA MedWatch reports submitted to FDA

378 views • 15 slides

The fate of inhaled drugs The fate of inhaled drugs Mark Everard Sheffield Childrens Hospital

The fate of inhaled drugs The fate of inhaled drugs Mark Everard Sheffield Childrens Hospital Why Used Inhaled Therapy? Drug is delivered directly to site of action Spahan JD, Szefler SJ Pediatric Respiratory Medicine 2008 Oral vs

296 views • 28 slides

RECENT ADVANCES ANTI PARKINSONIAN DRUGS ANTI PARKINSONIAN DRUGS 1 Swetha E.S, 2 Sathisha Aithal,

RECENT ADVANCES ANTI PARKINSONIAN DRUGS ANTI PARKINSONIAN DRUGS 1 Swetha E.S, 2 Sathisha Aithal, 3 Ayesha Rubina 1,3 Postgraduates, 2 Professor Department of Pharmacology, SSIMSRC, Davangere Brief overview Introduction Symptoms

616 views • 33 slides

Medicine and Drugs Types of Medicines People use medicines to help restore their health when

Chapter 19: Medicine and Drugs Types of Medicines People use medicines to help restore their health when they are ill Medicines are drugs that are used to treat or prevent disease or other conditions Drugs are substance other

309 views • 16 slides

On behalf of the NCCRED Clinical Research Network Methamphetamine and Emerging Drugs Working Group

National Centre for Clinical Research on Emerging Drugs An Australian clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern Krista J Siefried 1,2 ; Quoc Nguyen 1,2 ; Nadine

322 views • 13 slides

WHAT DO WE NEED TO DO TO KEEP PEOPLE WHO USE DRUGS ALIVE AND MOVING TOWARD WELLNESS? OUTLINE

WHAT DO WE NEED TO DO TO KEEP PEOPLE WHO USE DRUGS ALIVE AND MOVING TOWARD WELLNESS? OUTLINE Background Why work with people who use drugs? Theoretical perspective and harm reduction The Barcelona Model Outcomes

355 views • 17 slides

Optimizing Dosing of Oncology Drugs Optimizing Dosing of Oncology Drugs Richard L. Schilsky, M.D.

Optimizing Dosing of Oncology Drugs Optimizing Dosing of Oncology Drugs Richard L. Schilsky, M.D. American Society of Clinical Oncology Current Approach to Dose Determination in Oncology Aimed at the maximum - tolerated dose (MTD) to

840 views • 56 slides